132 results on '"Sousos, Nikolaos"'
Search Results
2. Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
3. In utero origin of myelofibrosis presenting in adult monozygotic twins
4. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
5. A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
6. Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice.
7. Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
8. Artificial intelligence–based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients
9. Platelets Sequester Extracellular DNA, Capturing Tumour-Derived and Free Fetal DNA
10. A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin 1 axis
11. Data from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
12. Supp Table 1 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
13. Supp Table 2 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
14. Supp Table 3 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
15. Supp Table 4 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
16. Supp Table 5 from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
17. Supplementary Information from Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
18. 3031 – CHROMOTHRIPSIS AND LEUKEMIC TRANSFORMATION IN MPN
19. The Clocks Start Ticking Earlier Than We Thought
20. Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
21. Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients
22. Cross-Talk between Hematopoietic Cells and Fibroblast Subsets Drives Inflammation and Remodelling of the Bone Marrow Microenvironment in Myeloproliferative Neoplasms
23. Human Bone Marrow Organoids Enable the Study of Hematopoietic Cell-Stromal Interactions and Support the Survival of Malignant Cells from Patients
24. Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies
25. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
26. Multipartite super-enhancers function in an orientation-dependent manner
27. Deciphering TP53 mutant Cancer Evolution with Single-Cell Multi-Omics
28. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
29. 3170 – SINGLE-CELL MULTI-OMICS RESOLVES THE EVOLUTION OF TP53-MUTANT LEUKEMIA
30. Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms
31. A Multiomic Single-Cell Atlas of Human Myelopoiesis Reveals Cellular and Molecular Drivers of Immunomodulatory Drug-Induced Neutropenia
32. Single-Cell Mutation Profiling and Alternative Splicing Analysis Reveals Distinct Aberrant Splicing of U2AF1S34 and U2AF1Q157 in Myeloid Malignancies
33. Platelet-Restricted Clonal Hematopoiesis
34. Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?
35. Single-cell analyses reveal aberrant pathways for megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets
36. Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
37. Molecular Characterisation of Participants in the Phazar Trial Reveals Prognostic Impact of Mutations in Advanced-Phase-MPN
38. Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis
39. Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets
40. Cutaneous manifestations of mantle cell lymphoma: an extensive literature review
41. Low‐dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms
42. Improving the diagnosis and classification of Ph-negative myeloproliferative neoplasms through deep phenotyping
43. Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
44. Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing
45. Unraveling intratumoral heterogeneity through high-sensitivity single-cell mutational analysis and parallel RNA-sequencing
46. Single Cell Analysis Resolves Genetic and Transcriptional Heterogeneity in Myeloproliferative Neoplasms
47. Deferasirox improves liver fibrosis in beta‐thalassaemia major patients. A five‐year longitudinal study from a single thalassaemia centre
48. Presence of the IVS-I-6-Mutated Allele in Beta-Thalassemia Major Patients Correlates with Extramedullary Hematopoiesis Incidence
49. 3149 - Single Cell Analysis Resolves Genetic and Transcriptional Heterogeneity in Myeloproliferative Neoplasms
50. Single-Cell Mutation Profiling and Alternative Splicing Analysis Reveals Distinct Aberrant Splicing of U2AF1S34and U2AF1Q157in Myeloid Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.